查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1179910

2023-2030 年全球 NIBP（无创血压）市场

Global Non-Invasive Blood Pressure Monitors Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内（2023-2030 年），NIBP（无创血压）的全球市场规模预计将以 7.0% 的复合年增长率增长。

血压计在医院中用于测量危重病人和接受手术的病人的血压。 血压计用于手术室、重症监护病房、手术恢復室、急诊室和其他重症监护区域，以定期或连续测量血压。 血压在诊断中起着重要作用，因此在患者病情危重时进行检查。

市场动态

全球对高血压和心血管疾病的控制和政府控制、老年人口增加以及 NIBP（无创血压）计的技术进步是预测期内推动市场的因素。.

对 NIBP（无创血压）的持续研究有望推动市场增长。

BPro（Healthstats，新加坡）是一款用于动态血压测量的腕式桡动脉压力监测仪。 最初使用上臂袖带装置进行校准。 本表将在校准后至少 24 小时内提供准确结果。 该设备由一个带有简单图形用户界面的表头和一个压在桡动脉上的柱塞组成。 柱塞由校准医疗保健专业人员用胶带固定在手腕上，以确保它在使用过程中不会移动。 根据 AAMI 和 ESH 标准，该设备已经过验证，可以分别将 SBP 和 DBP 测量到 (0.9 7.6) mmHg 和 (1.1 6.1) mmHg。

此外，图尔库大学的一个研究小组在 2020 年提出了一种桌面型血压计，即手指动脉无创张力计监测仪 (FANTOM)。 使用眼压计无袖口机电系统，对指尖施加压力并测量示波法血压。 可以测量动脉波形和中心血压 (CBP)。 将此设备与自动手臂袖带监测器进行比较的可选验证协议产生的 SBP 和 DBP 结果分别为 (0.9 7.3) mmHg 和 (3.3 6.6) mmHg。 因此，无袖带无创血压 (NIBP) 的研究进展有望成为预测期内的推动力。

无创血压测量的缺点预计会阻碍市场增长。

无创血压测量在极端压力下不可靠，并且无法进行连续监测。 此外，将其设置为过于频繁地重复可能会很痛苦，并且需要手动干预才能获得最大的准确性（即自动模式在不稳定的患者中不可靠）。 因此，预计上述因素将在预测期内阻碍市场。

COVID-19 影响分析

COVID-19 大流行对 NIBP（无创血压）市场产生了一定影响。 当 COVID-19 病例开始在全球范围内上升时，专家们意识到这对患有心脏病和相关疾病（尤其是高血压）的人来说尤其危险。 在美国，有 1.03 亿人（约占成年人的一半）患有高血压（也称为高血压）。 更糟糕的是，只有四分之一的成年人的血压得到控制。 不受控制的血压会导致严重的并发症，例如心脏病发作和中风。 随着 COVID-19 流行病的持续，新的问题又出现了。 患有高血压的人可能更容易受到更致命和更严重的冠状病毒副作用的影响。 因此，对无创血压计的需求越来越大。

此外，COVID-19 还有另一个潜在的有害影响。 由于担心感染冠状病毒，许多患者正在避开当地医院和急诊室。 全国各地的医院报告说，因紧急医疗需求前来就诊的患者越来越少。 但一些专家认为，这并不是因为患者拖延或拖延治疗，而是因为病例数在下降。 因此，预计市场将在预测期内受到上述因素的影响和改善。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 对 NIBP（无创血压）监测仪的持续研究有望推动市场增长。
    • 约束因素
      • 无创血压测量的缺点预计会阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 搬运工的五种力量
  • 供应链
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按设备类型

  • 自动血压计
  • 门诊血压计
  • 血压计
  • 血压传感器

第八章技术

  • 数字
  • 无液液体
  • 可穿戴设备

第9章配件

  • 血压计
  • 压力计
  • 阀门和管道
  • 阀门

第 10 章最终用户

  • 医院
  • 诊所
  • 门诊手术中心
  • 家庭医疗
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第13章公司简介

  • GE Healthcare
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • SOMNOmedics
  • Eccosur SA
  • Koninklijke Philips N.V.
  • Huntleigh Technology Ltd.
  • Mortara Instrument
  • Schiller Americans Inc.
  • American Diagnostic Corporation
  • Welch Allyn

第 14 章全球 NIBP（无创血压）市场数据 M

简介目录
Product Code: DMMD56

Market Overview

The global non-invasive blood pressure monitors market size was valued US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 7.0% during the forecast period (2023-2030).

Blood pressure monitors are used in hospitals to measure the blood pressure of patients who are critically ill or will be operated on for any surgical procedure. Blood pressure monitors are used in the operating room, intensive care units, surgical recovery rooms, emergency departments, and other critical care areas to measure blood pressure regularly or continuously. Blood pressure is checked during a patient's critical condition because it plays an important role in diagnosis.

Market Dynamics

The global rise of hypertension and cardiovascular diseases and governmental control, the rising geriatric population, and technological advancement in non-invasive blood pressure monitors are the factors to drive the market in the forecast period.

Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.

BPro (Healthstats, Singapore) is a wristwatch radial artery tonometer for ambulatory blood pressure measurement. It is calibrated with a brachial cuff device at first. The watch provides accurate results for at least 24 hours after calibration. The device comprises a watch head with a simple graphic user interface and a plunger to be pressed against the radial artery. The plunger is taped to the wrist by the healthcare professional performing the calibration to prevent it from moving while in use. The device has been validated in accordance with the AAMI and ESH standards, with SBP and DBP readings of (0.9 7.6) mmHg and (1.1 6.1) mmHg, respectively.

Furthermore, in 2020, a research group at the University of Turku proposed a tabletop form factor blood pressure instrument, the finger artery non-invasive tonooscillometric monitor (FANTOM). A tonometric cuffless mechatronic system is used to apply pressure to the fingertip and measure blood pressure using an oscillometric method. The device can measure arterial waveforms and central blood pressure (CBP). An arbitrary validation protocol comparing the device to an automated arm cuff monitor produced SBP and DBP results of (0.9 7.3) mmHg and (3.3 6.6) mmHg, respectively. Therefore, the ongoing research for cuffless non-invasive blood pressure monitors is expected to drive in the forecast period.

Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.

Non-invasive blood pressure measurement is less reliable at pressure extremes, and continuous monitoring is not possible; it can be painful if set to repeat too frequently and requires manual operation for maximum accuracy (i.e., automatic modes are unreliable in unstable patients). Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted the non-invasive blood pressure monitors market moderately. Experts realized that COVID-19 was especially dangerous for people with heart disease and related conditions, especially high blood pressure when cases of the virus started to rise globally. One hundred three million adults in the United States, or nearly half of all adults, have high blood pressure, also referred to as hypertension. Even more concerning is the fact that only 1 in 4 adults have their blood pressure under control. Uncontrolled blood pressure can result in severe complications like heart attack and stroke. As COVID-19 outbreaks persisted, a new issue surfaced. High blood pressure sufferers may be susceptible to more fatal and severe coronavirus side effects. As a result, there is now more of a demand for non-invasive blood pressure monitors.

In addition, COVID-19 has another potentially harmful effect. It has caused many patients to avoid their local hospitals and emergency rooms because they might contract the coronavirus. Hospitals across the nation are reporting a decrease in visits for urgent medical needs. Still, some experts think this isn't because patients are experiencing fewer of them rather than because they are putting off or postponing seeking treatment. Thus, from the above factors, the market got affected and is expected to improve in the forecast period.

Segment Analysis

Digital segment is expected to hold the largest market share in non-invasive blood pressure monitors

The digital segment accounted for the largest market share in 2021. The convenience that a digital blood pressure monitor provides in its mode of operation. They are ideal for use at home, particularly if the patient takes blood pressure readings. They employ electronic pressure sensors to assist in the measurement of blood pressure. As a result, readings are displayed digitally on a screen. A digital blood pressure monitor will help save time. It will save the patient from paying unnecessary fees to doctors who help you monitor their blood pressure. While most are battery-powered, some models are designed for field use and have dual power sources, including solar and battery cells.

Furthermore, digital blood pressure monitors are an excellent choice for people who have hearing or vision impairments. Some even provide paper printouts to assist you in keeping records. This helps your doctor evaluate your health at your next appointment. Therefore, it has increased the demand for digital non-invasive blood pressure monitors. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global non-invasive blood pressure monitors market

North America region accounted for the largest market share in 2021. The rising geriatric population, rising incidence of hypertension, increasing prevalence of cardiovascular disease, technological advancement in non-invasive blood pressure monitors, and product launches by the market players are the factors driving market growth in the forecast period. For instance, according to the Centers for Disease Control and Prevention, Hypertension increases the risk of heart disease and stroke, which are the leading causes of death in the United States. Hypertension was a primary or contributing cause of more than 670,000 deaths in the United States in 2020. Only about one in every four adults (24%) has hypertension under control. Uncontrolled hypertension affects roughly half of all adults (45%), with a blood pressure of 140/90 mmHg or higher. This includes 37 million adults in the United States.

Furthermore, On August 31, 2022, Sensifree LTD received a CE certificate for SentiCor-100 in compliance with the new EU MDR. SentiCor-100 is the world's first PPG-based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device approved for hospital use. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the non-invasive blood pressure monitors market are GE Healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd., Mortara Instrument, Schiller Americans Inc., American Diagnostic Corporation and Welch Allyn.

GE Healthcare:

Overview:

GE Healthcare is a subsidiary of the American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures as of 2017. Dyes for magnetic-resonance imaging methods are available from the firm. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines. Moreover, it develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. The company is operated in more than 100 countries.

Product Portfolio:

CRITIKON SOFT-CUF Blood Pressure Cuffs: CRITIKON SOFT-CUF is made of soft, absorbent material with rounded corners to maximize patient comfort during long hospital stays. These cuffs are ideal for patients with longer-term stays or protocols in which the cuff travels with the patient throughout their stay. It can be cleaned and reused on multiple patients. Still, it is reasonably priced so that it can be discarded after single-patient use, allowing for preventing infections more affordably.

The global non-invasive blood pressure Monitors market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Automated BP Monitors*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Ambulatory BP Monitors
  • 7.4. Sphygmomanometers
  • 7.5. BP Transducers

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Aneroid
  • 8.4. Wearable

9. By Accessory

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 9.1.2. Market Attractiveness Index, By Accessory
  • 9.2. Blood Pressure Cuffs*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Manometers
  • 9.4. Valves and Tubing
  • 9.5. Bulbs

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user
  • 10.2. Hospitals*
      • 10.2.1.1. Introduction
      • 10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Center
  • 10.5. Home Care Setting
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE Healthcare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. SOMNOmedics
  • 13.3. Eccosur SA
  • 13.4. Koninklijke Philips N.V.
  • 13.5. Huntleigh Technology Ltd.
  • 13.6. Mortara Instrument
  • 13.7. Schiller Americans Inc.
  • 13.8. American Diagnostic Corporation
  • 13.9. Welch Allyn

LIST NOT EXHAUSTIVE

14. Global Non-Invasive Blood Pressure Monitors Market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us